114-hr-5127114th Congress

Curb Opioid Misuse By Advancing Technology Act of 2016

Sponsored By: Representative Griffith, H. Morgan [R-VA-9]

Unknown

Summary

Curb Opioid Misuse By Advancing Technology Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to extend the marketing exclusivity period for certain brand name drugs that the Food and Drug Administration approves: (1) on the basis of new clinical abuse potential studies, and (2) with labeling that characterizes the drug's abuse-deterrent properties. This extension does not apply to the marketing exclusivity period for new chemical entities. The bill also extends the marketing exclusivity period for generics of these drugs.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Griffith, H. Morgan [R-VA-9]

VA • R

Cosponsors

  • Rep. Connolly, Gerald E. [D-VA-11]

    VA • D

    Sponsored 4/29/2016

  • Rep. Bilirakis, Gus M. [R-FL-12]

    FL • R

    Sponsored 4/29/2016

  • Rep. Collins, Chris [R-NY-27]

    NY • R

    Sponsored 6/15/2016

  • Rep. Boyle, Brendan F. [D-PA-2]

    PA • D

    Sponsored 6/28/2016

  • Rep. Fitzpatrick, Michael G. [R-PA-8]

    PA • R

    Sponsored 7/7/2016

  • Rep. Veasey, Marc A. [D-TX-33]

    TX • D

    Sponsored 9/8/2016

  • Rep. Dold, Robert J. [R-IL-10]

    IL • R

    Sponsored 9/8/2016

  • Rep. Stewart, Chris [R-UT-2]

    UT • R

    Sponsored 9/19/2016

  • Rep. Wilson, Frederica S. [D-FL-24]

    FL • D

    Sponsored 11/14/2016

  • Sen. Blackburn, Marsha [R-TN]

    TN • R

    Sponsored 11/14/2016

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation